Gary Patou

Insider Reports History

Entity
Individual
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary Patou:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Director Common Shares 23.6K $968K $41.05 Nov 22, 2024 Direct
Xenon Pharmaceuticals Inc. Director Common Shares 4.9K $201K $41.05 Nov 22, 2024 Indirect
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Nov 22, 2024 Direct

Insider Reports Filed by Gary Patou

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Nov 22, 2024 8 -$201K 4 Nov 22, 2024 Director
XENE Xenon Pharmaceuticals Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
XENE Xenon Pharmaceuticals Inc. Dec 13, 2023 1 -$312K 4/A Dec 15, 2023 Director
XENE Xenon Pharmaceuticals Inc. Jun 2, 2023 1 $0 4 Jun 2, 2023 Director
XENE Xenon Pharmaceuticals Inc. Nov 23, 2022 5 -$137K 4 Nov 28, 2022 Director
XENE Xenon Pharmaceuticals Inc. Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
XENE Xenon Pharmaceuticals Inc. Dec 8, 2021 2 $7.55K 4 Dec 10, 2021 Director
XENE Xenon Pharmaceuticals Inc. Mar 17, 2021 2 $1.95K 4 Jun 4, 2021 Director